Effects of chromium supplementation on growth rate and selected metabolic indexes including interactions with trace elements (zinc, copper) were investigated in 8-month-old bulls divided into one experimental (E, n = 8) and one control (C, n = 9) groups with mean live weights 284.9 ± 33.9 and 279.6 ± 27.0 kg, respectively. The experimental group was fed a diet supplemented with chromium-enriched yeasts (Co-Factor III Chromium Yeast, Alltech, 0.1% Cr 3+ ) at a dose corresponding to the intake of 5 mg of Cr per animal per day in the first phase (up to day 136) and 8 g per animal per day in the second phase (days 136 to 220) of the fattening period. The bulls were weighed and blood samples were collected on days 1, 136 and 220 of the experimental period. Favourable effects of chromium supplementation were evident from higher weight gains in the first fattening phase (1.04 ± 0.12 vs. 0.82 ± 0.12 kg; p ≤ 0.01). The between-group difference diminished and became now significant in the second phase of the fattening period (0.82 ± 0.12 vs. 0.74 ± 0.14 kg).
Chromium is a transitional element involved in many oxidative events. The topics of interest are its essentiality and toxicity. The interest in chromium as an essential element has grown in the recent years (Lindemann 1998) . Biologically active are Cr 3+ and Cr 6+ , but some differences in their metabolism are known. Cr 6+ is more readily absorbed than Cr 3+ , but its toxicity is higher. Therefore, more information on Cr 3+ is available.
Chromium can be involved in several biological functions. However, its major role seems to be enhancement of the action of insulin. Chromium, as an integral component of the Glucose Tolerance Factor (GTF), binds insulin, which is responsible for the transport of glucose and amino acids into the cell, to cell membrane receptors. Such optimisation of insulin activity results in improved regulation of glucose intake by cells and thereby in a better control of blood glucose concentration and maximum utilization of the energetic potential.
Chromium ranks with essential elements in humans and animals. Clinical manifestations of chromium deficiency have been summarised by Anderson et al. (1994) as follows: starvation hyperglycaemia, impaired glucose tolerance, increased concentration of circulating insulin, glycosuria, increased concentrations of cholesterol and triacylglycerols in blood serum, decreased concentration of bound insulin, and decrease in the number of insulin receptors. Supplementation with chromium is indicated particularly in animals exposed to strain. Results of recent experiments undertaken by North American scientists in pigs, cattle, horses and poultry have shown that chromium improves carcass quality by increasing meatiness and decreasing the fat content (Lindemann et al. 1995; Boleman et al. 1995; Money and Cromwell 1995) , and increases (Page et al. 1993; MoonsieShageer and Mowat 1993) and improves the efficacy of feed utilisation (Lindemann et al. 1995) . Further, a decrease in corticosteroid and cholesterol concentrations and also enhancement of immune responses to vaccination were described in subjects receiving chromium-supplemented rations (Burton et al. 1993; Chang et al. 1996; Mowat et al. 1993) . It must be noted, however, that the results of the individual authors are not consistent, apparently due to a strong dependence on other factors, such as growth phase, stress, contents of lysine, niacin, and saccharides in the ration, and level of chromium supply.
The objective of our experiment was to establish the effects of chromium supplementation on growth rate in bulls and selected metabolic indexes including the interaction with the trace elements zinc and copper.
Materials and Methods
The experiment was carried out in fattening bulls of a herd of Black Pied Lowland cattle in 1998 on the agricultural farm in Czech-Moravian Highland. Eight-month-old bulls were divided into an experimental (E, n = 8) and a control (C, n = 9) groups. Mean live weights in the experimental and the control groups were 284.9 ± 33.9 kg and 279.6 ± 27.0 kg, respectively. The bulls were fed a following ration: maize silage, clover-grass silage and concentrate. The mixture of concentrate contained wheat 40%, barley 27%, extract of rape-seed 15%, extract of soya bean 1%, minerals 3%). The characterisation of the ration according fattening period is in the Table 1 . The ration of the experimental group was supplemented with organic chromium in the form of chromium-enriched yeast (Co-Factor III Chromium Yeast, Alltech, 0.1% Cr 3+ ) at a dose corresponding to the intake of 5 mg Cr per animal per day in the first phase (up to day 136) and 8 mg Cr per animal per day in the second phase (days 137 to 220) of the fattening period. The bulls were weighed and blood samples were collected from v. jugularis at the beginning of the experiment and on days 136 and 220.
Blood plasma was analysed for the concentrations of some biochemical parameters. The analyses for total proteins, glucose, urea, cholesterol, triacylglycerols, AST (aspartate aminotransferase), GMT (gammaglutamyltransferase), CK (creatin kinase), LD (lactate dehydrogenase), ALP (alkaline phosphatase), and inorganic phosphorus were done using the automatic analyser Cobas Mira, and the minerals sodium, potassium, calcium, magnesium, zinc, and copper were determined by atomic absorption spectroscopy using the apparatus Hilger 1500.
The obtained data were processed by the F-test for the assessment of variations in the individual sets and, in dependence on results, by the double-tailed Student t-test for sets with equal/unequal variations using the EXCEL software. Statistical evaluation of obtained data is in the tables as mean (x) and standard deviation (SD). Table 1 Daily ration for bulls at the beginning of the first and second fattening period and at the end of the experiment 
Results and Discussion

Growth rate
The experiment demonstrated favourable effects of chromium supplementation on growth rate in bulls. The difference in weight gains between the experimental and the control bulls was highly significant in the first phase of the fattening period, but diminished to become no significant in the second phase. Weight gains for the individual phases are presented in Table 2 and growth dynamics are shown in Table 3 .
The difference in the first phase was apparently associated with a stronger stress to which the bulls were exposed and which resulted from relocation into new premises, a change in the epizootiological situation, and changes in social ranking within the newly formed groups. Considering the higher demand for chromium in animals exposed to stress (Lindemann 1996) and a lower stress susceptibility in subjects receiving chromium supplements (Kegley and Spears 1995; Moonsie-Shageer and Mowat 1993) , we can assume that just these mechanisms were responsible for the difference in the effects of chromium on weight gains in the first and the second phase of the fattening period. Similar results were reported by Chang et al. (1995) who also observed weaker effects of chromium combined with nicotinic acid on weight gains after day 28 of their experiment. The growth rate can be influenced also by favourable effects of chromium on the state of health and immunity as described by Mowat et al. (1993) . Increased weight gains in animals fed a chromium-supplemented ration were also reported by Mowat et al. (1993) and Kegley et al. (1997) for calves and Bonomi et al. (1998) for heifers. On the other hand, no effects of chromium on weight gains in fattened bulls were found by Danielsson and Pehrson (1998) and Mathison and Engstrom (1995) .
Metabolic profile
Significant between-group differences were observed in the concentrations of total protein (at 2 nd and 3 rd sampling), total cholesterol (at 2 nd sampling), phosphorus (at 2 nd Table 2 Mean weight gains (mean ± SD) of bulls during the experimental period in the experimental (E; n = 8) and control (C; n = 9) group sampling), magnesium (at 3 rd sampling), and copper (at 2 nd and 3 rd sampling). Selected values of the metabolic profile in the experimental and the control groups are shown in Tables 4 and 5 . Analyses for nitrogenous substances demonstrated a significantly higher concentration of total blood plasma proteins at 2 nd and 3 rd sampling and a no significantly lower concentration of urea in the experimental group throughout the experimental period. We assume that the differences were due to the more intensive proteosynthesis and a lesser amount of residual nitrogen, which is detoxified in the liver within the ureasynthetic cycle. This finding is in agreement with the known mechanism of action of chromium consisting in the improvement of amino acid entry into and proteosynthesis in muscular cells (Evans and Bowman 1992) .
No significant between-group differences were found in indexes of energy metabolism. The glucose concentration was relatively high varying between 4 and 5 mmol⋅l -1 , which is a moderate increase above the physiological range of 3.0 to 3.9 mmol⋅l -1 (Vrzgula et al. 1987 ). The glucose concentration was largely ration-dependent and was not influenced by chromium supplementation. To a certain extent, this finding contradicts the presumed role of chromium in the GTF, which moderates the fluctuation of glycaemia and enhances glucose catching by cells. However, the range of glycaemia, which is influenced by chromium, is also important in considerations on the mechanism of action. A certain role might be played by the content of dietary nicotinic acid, which influences the responsiveness Table 4 Selected indexes of metabolic profiles (mean ± SD) in blood plasma during the experimental period in control (C; n = 9) and experimental (E; n =8) bulls of the organism to chromium supplementation (Urberg and Zemel 1987) . Absence of effect of chromium on glycaemia in calves was reported also by Bunting et al. (1994) . A significance between-group difference was also found in the concentration of total cholesterol, which was lower in the control than in the experimental group on day 136. Since some difference was observed already at the beginning of the experiment, it can be interpreted rather as an individual characteristic of the randomly formed groups than as an effect of chromium supplementation, which became apparent in the course of the experiment only.
Enzyme profile was monitored throughout the experiment to detect possible adverse effects of chromium. A high safety of chromium was demonstrated by the absence of any deviations from normal values. No signs of toxicity were observed in humans receiving up to 1 mg of Cr 3+ per day (Barceloux 1999) .
Certain differences between the experimental and the control groups were found also in the metabolism of minerals. Compared with controls, the experimental group showed significantly lower concentrations of phosphorus at 2 nd sampling and of magnesium at 3 rd sampling. These differences are rather difficult to explain, because each of them was found at one sampling only and none of the values exceeded the physiological range. Both phosphorus and magnesium are closely associated with energy metabolism and the low blood concentrations may have been due to a higher demand in animals with a higher growth rate. The marked decrease in the phosphorus concentration at 2 nd sampling was reflected also in increased activity of ALP in both groups which was indicative of an alteration in bone tissue due apparently to phosphorus deficiency. Published data on alterations in mineral metabolism in animals fed a diet supplemented with chromium is rather scarce. MoonsieShageer and observed an only temporal increase of calcium and magnesium concentrations in calves.
Interesting data resulted also from the monitoring of trace element concentrations. Compared with the experimental group, copper concentration in blood plasma of controls was significantly lower. The concentration decreased throughout the experimental period. While the difference between 2 nd and 3 rd sampling was significant (p ≤ 0.05) in the control Table 5 Selected indexes of blood plasma mineral profile (mean ± SD) of control (C; n = 9) and experimental (E; n = 8) group, the decrease was less marked in the experimental group and the differences between samplings were non-significant. Interactions among trace elements are very complex and only few relevant data is available. Interactions of copper with zinc, selenium, cadmium, mercury, lead, and iron were investigated, but little is known about relations between copper and chromium. Zinc concentration remained constant during the experimental period indicating the absence of effects of chromium supplementation.
Vliv dotace chromu na intenzitu rÛstu a metabolismus b˘kÛ ve v˘krmu
Byl realizován pokus s cílem sledování vlivu dotace Cr na rÛst b˘kÛ a vybrané parametry metabolismu vãetnû interakcí se stopov˘mi prvky (Zn, Cu).
Ve v˘krmnû b˘kÛ byly vytvofieny dvû skupiny -pokusná (8 ks) a kontrolní (9 ks), kam byli zafiazeni b˘ci ve stáfií 8 mûsícÛ. PrÛmûrná Ïivá hmotnost b˘kÛ pokusné skupiny byla 284,9 ± 33,9 kg a kontrolní skupiny 279,6 ± 27,0 kg. B˘kÛm pokusné skupiny byl podáván chrom v dávce 5 mg/kus/den v první fázi v˘krmu (136 dnÛ) a ve druhé fázi v˘krmu (137 -220 dní) v dávce 8 mg/kus/den v organické formû Cr-kvasinek (Co-Factor III Chromium Yeast, Alltech, 0,1% Cr 3+ ). V prÛbûhu pokusu byla sledována hmotnost b˘kÛ váÏením a byla odebírána krev na biochemické vy‰etfiení.
Byl prokázán pozitivní vliv dotace chromu na rÛst b˘kÛ. Dotace chromu ovlivnila pozitivnû v˘‰i pfiírÛstkÛ (p ≤ 0,01) v první fázi v˘krmu (1,04 ± 0,12 vs. 0,82 ± 0,12 kg⋅den -1 ), ve druhé fázi v˘krmu rozdíly mezi pokusnou a kontrolní skupinou nebyly signifikantní (0,82 ± 0,12 vs. 0,74 ± 0,14 kg⋅den -1 ).
V metabolickém profilu byla u pokusné skupiny zji‰tûna signifikantnû vy‰‰í koncentrace (p ≤ 0,01) celkové bílkoviny v krevní plazmû (136. den pokusu 82,4 ± 2,98 vs. 77,31 ± 3,48 g⋅l -1 , 220.den 71,35 ± 4,07 vs. 64,09 ± 4,96 g⋅l -1 ). Koncentrace celkového cholesterolu byla signifikantnû vy‰‰í (p ≤ 0,05) u pokusné skupiny 136. den (2,40 ± 0,31 vs. 2,06 ± 0,24 mmol⋅l -1 ). Z minerálních látek byly zji‰tûny v pokusné skupinû niÏ‰í koncentrace (p ≤ 0,05) fosforu (136.den 2,07 ± 0,14 vs. 2,26 ± 0,16 mmol⋅l -1 ), hofiãíku (220. den 0,88 ± 0,04 vs. 0,94 ± 0,05 mmol⋅l -1 ) a naopak vy‰‰í koncentrace (p ≤ 0,05) mûdi (136. den 17,48 ± 1,12 vs. 15,94 ± 1,50 µmol⋅l -1 , 220. den 15,79 ± 2,15 vs. 13,62 ± 1,69 µmol⋅l -1 ). Koncentrace glukózy, moãoviny, AST, GMT, LD, ALP, CK, Na, K, Zn nebyly dotací chromu ovlivnûny.
